미국의 조영제 주입기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 유형별, 부문 예측(2025-2030년)

U.S. Contrast Media Injectors Market Size, Share & Trends Analysis Report By Product (Injector Systems, Consumables), By Application (Radiology, Interventional Cardiology), By Type, By End Use, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,251,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,638,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,411,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

미국의 조영제 주입기 시장 동향 :

미국의 조영제 주입기 시장 규모는 2024년에 6억 494만 달러에 달했고 2025년부터 2030년에 걸쳐 CAGR 10.08%를 나타낼 것으로 예측됩니다.

시장 성장의 배경에는 암, 심혈관질환, 신경질환 등의 만성질환의 이환율의 상승이 있습니다.

북미의 조영제 주입기 산업은 MRI, CT 스캔, 심혈관 조영 등의 화상 진단 수요 증가에 견인되어 대폭적인 성장이 전망되고 있습니다. 의료용 화상 진단은 다양한 질환의 조기 발견, 진단, 치료 계획에 있어서 매우 중요합니다.

게다가 2024년 2월에 CDC가 발표한 데이터에 의하면, 약 1억 2,900만명의 미국인이 적어도 1개의 주요 만성 질환을 가지고 생활하고 있는 것이 밝혀졌습니다. 영상 진단의 필요성이 강하게 증가하는 것이 부각되어 지역 전체의 조영제 주입 장치 수요를 더욱 밀어 올리고 있습니다.

조영제 주입기의 제품 출시와 규제 인가 증가는 시장 성장을 크게 촉진할 것으로 예측됩니다. 흐름을 강화하고 더 나은 영상 진단 실천을 지원함으로써 첨단 영상 진단 시스템의 광범위한 채택을 촉진하고 있습니다. 그 결과 안정적이고 효과적인 조영제 공급 솔루션에 대한 수요가 계속 증가하고 시장 확대에 더욱 박차를 가하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 미국의 조영제 주입기 시장 변수, 동향, 범위

• 시장 계통 전망
  • 관련/보조 시장 전망
• 사용자의 시점 분석
  • 소비자 행동 분석
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
  • 시장 기회 분석
  • 시장 과제 분석
• 미국의 조영제 주입기 시장 분석 툴
  • 업계 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 미국의 조영제 주입기 시장 : 제품 추정·동향 분석

• 정의와 범위
• 제품 시장 점유율(2018년 및 2030년)
• 부문 대시보드
• 미국의 조영제 주입기 시장 : 제품별 전망
• 시장 규모와 예측 및 동향 분석(2024-2030년)
  • 인젝터 시스템
  • 소모품

제5장 미국의 조영제 주입기 시장 : 유형 추정·동향 분석

• 정의와 범위
• 유형별 시장 점유율(2018년 및 2030년)
• 부문 대시보드
• 미국의 조영제 주입기 시장 : 유형별 전망
• 시장 규모와 예측 및 동향 분석(2024-2030년)
  • 싱글 헤드 인젝터
  • 듀얼 헤드 인젝터
  • 주사기 없는 인젝터

제6장 미국의 조영제 주입기 시장 : 용도 추정·동향 분석

• 정의와 범위
• 용도 시장 점유율(2018년 및 2030년)
• 부문 대시보드
• 미국의 조영제 주입기 시장 : 용도별 전망
• 시장 규모와 예측 및 동향 분석(2024-2030년)
  • 방사선학
  • 중재 심장학
  • 중재 방사선학

제7장 미국의 조영제 주입기 시장 : 최종 용도 추정·동향 분석

• 정의와 범위
• 최종 용도 시장 점유율(2018년 및 2030년)
• 부문 대시보드
• 미국의 조영제 주입기 시장 : 최종 용도별 전망
• 시장 규모와 예측 및 동향 분석(2024-2030년)
  • 병원
  • 진단센터
  • 외래수술센터(ASC)

제8장 경쟁 구도

• 주요 시장 진출기업에 의한 최근의 동향과 영향 분석
• 기업/경쟁의 분류
  • 이노베이터
• 벤더 상황
  • 주요 리셀러 및 채널 파트너 목록
  • Key customers
  • Key company market share analysis, 2024
  • Shenzhen Boon Medical Supply Co. Ltd.
  • Bracco Diagnostics Inc.
  • Bayer
  • Guerbet
  • ulrich GmbH &Co. KG
  • B.Braun SE
  • Shenzhen Antmed Co. Ltd.
  • Ecomed Solutions
  • Siemens Medical Solutions USA, Inc.(Siemens Healthineers AG)

KTH

영문 목차

영문목차

U.S. Contrast Media Injectors Market Trends:

The U.S. contrast media injectors market size was estimated at USD 604.94 million in 2024 and is projected to grow at a CAGR of 10.08% from 2025 to 2030. The market growth is attributed to the rising incidence of chronic conditions such as cancer, cardiovascular diseases, and neurological disorders. The rising number of chronic diseases is driving the demand for diagnostic imaging tests that use conventional imaging methods such as X-rays and ultrasounds, along with advanced imaging techniques such as CT scans and MRIs.

The North America contrast media injectors industry is expected to grow significantly, driven by the rising demand for imaging procedures such as MRI, CT scans, and cardiovascular angiography. This surge is fueled by advancements in imaging technology, an aging population, increasing awareness of preventive healthcare, and the growing prevalence of chronic diseases. Medical imaging is critical in early detection, diagnosis, and treatment planning for a wide range of conditions. According to a study published by the National Library of Medicine in October 2023, nearly 40 million MRI scans are performed annually in the U.S.

In addition, data from the CDC in February 2024 revealed that approximately 129 million Americans are living with at least one major chronic illness. This substantial burden of chronic disease, combined with the high volume of imaging tests performed each year, highlights a strong and growing need for diagnostic imaging, further driving demand for contrast media injectors across the region. Hence, the increasing prevalence of long-term diseases and complex comorbidities is one of the major drivers, as it is leading to an increase in demand for contrast media injectors.

The growing number of product launches and regulatory approvals for contrast media injectors is expected to drive market growth significantly. Companies are introducing advanced technologies, including syringeless and multi-patient injectors, to improve efficiency and patient outcomes. These innovations enhance operational workflows and support better imaging practices, encouraging broader adoption of advanced imaging systems. As a result, the demand for reliable and effective contrast media delivery solutions continues to rise, further fueling market expansion.

U.S. Contrast Media Injectors Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. contrast media injectors market report based on product, type, application, and end use:

• Product Outlook (Revenue, USD Million, 2018 - 2030)
• Injector Systems
  • CT injector systems
  • MRI injector systems
  • Cardiovascular/angiography injector systems
• Consumables
  • Tubing
  • Syringe
  • Others
• Type Outlook (Revenue, USD Million, 2018 - 2030)
• Single Head Injectors
• Dual-Head Injectors
• Syringeless Injectors
• Application Outlook (Revenue, USD Million, 2018 - 2030)
• Radiology
• Interventional Cardiology
• Interventional Radiology
• End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Diagnostics Centers
• Ambulatory Surgery Centers

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Third Party Perspective
  • 1.3.5. Primary research
  • 1.3.6. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights Outlook

Chapter 3. U.S. Contrast Media Injectors Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Related/ancillary market outlook.
• 3.2. User Perspective Analysis
  • 3.2.1. Consumer behavior analysis
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
    • 3.3.1.1. Increasing demand for imaging tests
    • 3.3.1.2. Rising launches and approvals of contrast media injectors
    • 3.3.1.3. Increasing prevalence of chronic disorders
    • 3.3.1.4. Growing adoption of syringe less injectors
  • 3.3.2. Market restraint analysis
    • 3.3.2.1. Potential complications and risks associated with contrast media injections
  • 3.3.3. Market opportunity analysis
    • 3.3.3.1. Rising number of distribution agreements
    • 3.3.3.2. Advancements in contrast media injectors
    • 3.3.3.3. Growing clinical trials for contrast media and injectors
  • 3.3.4. Market challenge analysis
    • 3.3.4.1. Shortage of radiologists and healthcare professionals
• 3.4. U.S. Contrast Media Injectors Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape

Chapter 4. U.S. Contrast Media Injectors Market: Product Estimates & Trend Analysis

• 4.1. Definitions and Scope
• 4.2. Product Market Share, 2018 & 2030
• 4.3. Segment Dashboard
• 4.4. U.S. Contrast Media Injectors Market by Product Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
  • 4.5.1. Injector Systems
    • 4.5.1.1. Injector systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.1.2. CT injector systems
      • 4.5.1.2.1. CT injector systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.1.3. MRI injector systems
      • 4.5.1.3.1. MRI injector systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.1.4. Cardiovascular/angiography injector systems
      • 4.5.1.4.1. Cardiovascular/angiography injector systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Consumables
    • 4.5.2.1. Consumables market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.2.2. Syringes
      • 4.5.2.2.1. Syringes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.2.3. Tubings
      • 4.5.2.3.1. Tubings market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.2.4. Others
      • 4.5.2.4.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Contrast Media Injectors Market: Type Estimates & Trend Analysis

• 5.1. Definitions and Scope
• 5.2. Type Market Share, 2018 & 2030
• 5.3. Segment Dashboard
• 5.4. U.S. Contrast Media Injectors Market by Type Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
  • 5.5.1. Single Head Injectors
    • 5.5.1.1. Single head injectors market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.2. Dual Head Injectors
    • 5.5.2.1. Dual head injectors market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.3. Syringeless Injectors
    • 5.5.3.1. Syringeless injectors market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. U.S. Contrast Media Injectors Market: Application Estimates & Trend Analysis

• 6.1. Definitions and Scope
• 6.2. Application Market Share, 2018 & 2030
• 6.3. Segment Dashboard
• 6.4. U.S. Contrast Media Injectors Market by Application Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
  • 6.5.1. Radiology
    • 6.5.1.1. Radiology market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.2. Interventional Cardiology
    • 6.5.2.1. Interventional cardiology market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.3. Interventional Radiology
    • 6.5.3.1. Interventional radiology market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. U.S. Contrast Media Injectors Market: End Use Estimates & Trend Analysis

• 7.1. Definitions and Scope
• 7.2. End Use Market Share, 2018 & 2030
• 7.3. Segment Dashboard
• 7.4. U.S. Contrast Media Injectors Market by End Use Outlook
• 7.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
  • 7.5.1. Hospitals
    • 7.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5.2. Diagnostics Centers
    • 7.5.2.1. Diagnostics centers market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5.3. Ambulatory Surgery Centers
    • 7.5.3.1. Ambulatory surgery centers market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
  • 8.2.1. Innovators
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2024
  • 8.3.4. Shenzhen Boon Medical Supply Co., Ltd.
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Bracco Diagnostics Inc.
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Bayer
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Guerbet
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. ulrich GmbH & Co. KG
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. B.Braun SE
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Shenzhen Antmed Co., Ltd.
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Ecomed Solutions
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Siemens Medical Solutions USA, Inc. (Siemens Healthineers AG)
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives

관련자료